The
fifth annual conference of Indian Society for Clinical Research (ISCR)
was recently held at Taj Krishna in Hyderabad. The theme for this year's
conference was ‘Beyond Efficiency to Excellence’ and was attended by
over 400 delegates from India and abroad.
Dr Prem
Kumar Reddy, a leading authority on cancer research, inaugurated the
conference and delivered the keynote address. This was followed by a
welcome address by Dr Krathish Bopanna, President, ISCR. Bindhya
Cariappa, Chairperson, Scientific Committee presented an overview of the
conference, which was followed by a vote of thanks by Dr Radhika Bobba,
Chairperson, Local Organising Committee.
 |
| A panel discussion in progress |
In synchrony
to ISCR's objective of ensuring that the conference serves as a platform
for the best minds in clinical research to share innovative views and
best practices in clinical research, this year’s sessions focussed on
excellence in line with the conference theme. The two-day conference had
two clinical research tracks that touched upon each aspect of clinical
development and covered early development, regulatory affairs, medical
writing, clinical research technology, ethics, investigator site
perspectives, project management, data management, quality assurance,
pharmacovigilance, biostatistics and a discussion on the perception of
clinical trials in India.
 |
| Delegates attended Akshaya, Mandar Kelkar, Dr.Parthasarathi, Anand Harugery |
The
conference was preceded by four workshops on study management, medical
writing, statistics and pharmacovigilance. Unique to this conference was
also the young clinical research debate conducted at the end of day one
of the conference. The conference was concluded by a valedictory speech
by Dr PM Bhargava, scientist and recipient of Padma Bhushan and a vote
of thanks to delegates, speakers, sponsors, organisers and volunteers.
Speakers
who attended the conference were Dr Rajesh Karan, Novartis; Dr Julius
Vaz, Dr Reddy's Laboratories; Dr Shreemanta K Parida, Dept of
Biotechnology; Dr Deven Parmar, Wockhardt; Dr Sudhakar Mairpadi,
Phillips; Shenaz Vakharia, Theraverity; Dr Shashidhar Rao, Novartis; Dr
Sanjay A Pai, Columbia Asia; Dr Roopa, Basrur, Parexel; Dr Graham Bunn,
Medidata Solutions; Gunjan Jain, Oracle; Dr SD Rajendran, Sristek; Dr
Ajay Parker, SIRO Clinpharm; Carol Isaacson Barash, Genetics, Ethics and
Policy Consulting; Dr Gauri Gholap, Optra Systems; Sudip Sinha,
CliniRx; Dr Mubarak Naqvi, Sanofi Aventis; Dr Aamir Shaikh, Assansa; Dr
Ajoy Roy, Parexel; Dhiren Joshi, Voisin Life Sciences; Vivek Ahuja,
Baxter; Dr Manish Kumar Shah, Pfizer; Narasimha Kumar, Parexel; Dr Sneha
Limaye, CRF; Dr Milind Antani, Nishith Desai Associates; Gourav Kumar,
Apollo Hospitals; Dr Vishwanath Iyer, Novartis; Dr Chitra Lele,
Sciformix; Tommy Pedersen, Quintiles; Bindhya Cariappa, ClinTec
international; Dr Rupam, KIMS; PV Rao, eminent media person; Dr Suresh
Menon, Novartis; Professor Sarma, NALSAR; Dr Nimita Limaye, Siro
Clinpharm; Dr Hema Bajaj, Sanofi Aventis; Mark Aubrey, Daiichi Sankyo;
Dr Raghunatha Rao, NIMS; Dr Purvish Parikh, Americares and Dr Senthil
Rajappa, Indo-American Cancer Hospital. The resounding success of the
conference has raised the bar for the sixth annual conference to be held
in Mumbai next year.
Source:ExpressPharma
